Funding for this research was provided by:
National Institutes of Health (R01CA129127, R01CA142580, SPORE in Head and Neck Cancer (P50CA097190) pilot fund, P50CA097190)
U.S. Department of Defense (PC150190)
Text and Data Mining valid from 2018-11-12
Received: 7 March 2018
Accepted: 17 October 2018
First Online: 12 November 2018
Ethics approval and consent to participate
: Human tissues used in this study are de-identified and publicly available. They are thus exempt from the requirement of IRB approval (Exempt Category 4). Cell lines were from ATCC, and a few of them were from Dr. Grandis. No ethics approval is needed for their use.Institutional Animal Care and Use Committee: All experimental procedures involving animals were approved by the University of Pittsburgh.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.